Foundation Fighting Blindness Retinal Degeneration Fund Insider Trades & Stock Holdings

Director · Opus Genetics, Inc. · Latest filing Sep 30, 2026

Foundation Fighting Blindness Retinal Degeneration Fund, Director at Opus Genetics, Inc. has 1 Form 4 trade on file since Sep 30, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($2.76M), net -$2.76M. Latest filing: disposed of 556K shares of $IRD on Sep 30, 2026 at $4.96.

Trades on file

1

Open-market bought

$0

Open-market sold

$2.76M

Net open-market

-$2.76M

Latest filing

Sep 30, 2026

All insider trades by Foundation Fighting Blindness Retinal Degeneration Fund

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Sep 30, 2026	$IRD	Sell (Open-market sale)	556K	$4.96	$2.76M			-8.9%			Director		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Foundation Fighting Blindness Retinal Degeneration Fund traded

• $IRD

Frequently asked questions

Has Foundation Fighting Blindness Retinal Degeneration Fund been buying or selling stock?

Foundation Fighting Blindness Retinal Degeneration Fund has 0 open-market purchases and 1 open-market sale on file, net -$2.76M. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Foundation Fighting Blindness Retinal Degeneration Fund's latest insider trade?

disposed of 556K shares of $IRD on Sep 30, 2026 at $4.96.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.